Bausch Health Companies Inc traded at 10.76 this Thursday June 30th, decreasing 0.22 or 2.00 percent since the previous trading session. Looking back, over the last four weeks, Bausch Health Companies Inc lost 12.45 percent. Over the last 12 months, its price fell by 70.77 percent. Looking ahead, we forecast Bausch Health Companies Inc to be priced at 10.52 by the end of this quarter and at 9.82 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
10.76
Daily Change
-2.00%
Yearly
-70.77%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Aurora Cannabis Inc 1.70 -0.06 -3.41% -83.98%
Amgen 245.55 2.25 0.92% -1.27%
ANI Pharmaceuticals 31.54 1.87 6.29% -10.00%
Biogen 210.63 6.69 3.28% -39.60%
Bristol-Myers Squibb 76.84 -0.16 -0.21% 14.77%
Corcept Therapeutics 25.44 1.66 6.98% 14.03%
Catalent 107.02 -0.27 -0.25% -3.69%
Danaher 258.05 4.53 1.79% -5.83%
Endo International 0.57 0.10 22.42% -86.74%
Gilead Sciences 62.36 0.55 0.89% -10.01%
Horizon Pharma 80.84 1.08 1.35% -15.68%
Jazz Pharmaceuticals 158.58 2.57 1.65% -12.63%
Lannett 0.56 -0.02 -3.46% -87.85%
Eli Lilly 324.71 0.48 0.15% 38.79%
Nektar Therapeutics 3.75 -0.05 -1.32% -78.08%
Phibro Animal Health 19.59 0.46 2.40% -33.68%
Prestige Brands 59.58 0.78 1.33% 14.14%
Pacira 57.85 -0.45 -0.77% -2.41%
Perrigo 41.02 0.45 1.11% -12.56%
Drreddys Laboratories 55.84 0.45 0.81% -25.83%
Revance Therapeutics 14.33 0.51 3.69% -52.85%
Supernus Pharmaceuticals 29.35 0.43 1.49% -3.36%
Vertex Pharmaceuticals 287.32 5.53 1.96% 43.27%
Bausch Health Companies Inc 10.76 -0.22 -2.00% -70.77%
Canopy Growth Corp 3.66 -0.83 -18.49% -87.25%
Zoetis 174.21 2.32 1.35% -9.60%

Indexes Price Day Year
CATSX 18861 -217.28 -1.14% -6.75%

Bausch Health Companies Inc
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.